Sunday, July 12, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “inhibitor”

2,878 pharma patents match "inhibitor" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,878
Index total 30,257
Page 54 / 120

Quick answer

This filtered view shows 2,878 pharmaceutical patents matching "inhibitor" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,878 results for “inhibitor” · 30,257 patents in full index Clear search

  1. US 9957281

    Benzodiazepine derivatives as RSV inhibitors

    Enanta Pharmaceuticals, Inc. · Granted May 1, 2018 · Expires Apr 26, 2038

    granted

  2. US 9957259

    Selective HDAC1 and HDAC2 inhibitors

    Regenacy Pharmaceuticals, Inc. · Granted May 1, 2018 · Expires Apr 26, 2038

    granted

  3. US 9951078

    Inhibitors of ERK and methods of use

    Kura Oncology, Inc. · Granted Apr 24, 2018 · Expires Apr 19, 2038

    granted

  4. US 9949932

    Formulation of syk inhibitors

    GILEAD CONNECTICUT, INC. · Granted Apr 24, 2018 · Expires Apr 19, 2038

    granted

  5. US 9951014

    Mammalian and bacterial nitric oxide synthase inhibitors

    Northwestern University · Granted Apr 24, 2018 · Expires Apr 19, 2038

    granted

  6. US 9944626

    6-(5-hydroxy-1H-pyrazol-1-YL)nicotinamide inhibitors of PHD

    Takeda Pharmaceutical Company Limited · Granted Apr 17, 2018 · Expires Apr 12, 2038

    granted

  7. US 9938272

    Hydrazine compound as blood coagulation factor Xa inhibitor

    North China Pharmaceutical Company., Ltd. · Granted Apr 10, 2018 · Expires Apr 5, 2038

    granted

  8. US 9937157

    Modified release dosage forms of xanthine oxidoreductase inhibitor or xanthine oxidase inhibitors

    Takeda Pharmaceuticals U.S.A., Inc. · Granted Apr 10, 2018 · Expires Apr 5, 2038

    granted

  9. US 9937228

    Treatment of myocardial infarction by inhibiting the action of mAKAPβ

    Anchored RSK3 Inhibitors, LLC · Granted Apr 10, 2018 · Expires Apr 5, 2038

    granted

  10. US 9937155

    Methods of use for trisubstituted benzotriazole derivatives as dihydroorotate oxygenase inhibitors

    Aurigene Discovery Technologies Limited · Granted Apr 10, 2018 · Expires Apr 5, 2038

    granted

  11. US 9931340

    Pyridazinone compounds and their use as DAAO inhibitors

    Takeda Pharmaceutical Company Limited · Granted Apr 3, 2018 · Expires Mar 29, 2038

    granted

  12. US 9925188

    DNA-PK inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Mar 27, 2018 · Expires Mar 22, 2038

    granted

  13. US 9918983

    Suicidal LSD1 inhibitors targeting SOX2-expressing cancer cells

    THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF NEVADA, LAS VEGAS · Granted Mar 20, 2018 · Expires Mar 15, 2038

    granted

  14. US 9918939

    Formulation of Syk inhibitors

    GILEAD CONNECTICUT, INC. · Granted Mar 20, 2018 · Expires Mar 15, 2038

    granted

  15. US 9919065

    Somatostatin analogs with inhibitory activity to growth hormone release

    The Regents of the University of California · Granted Mar 20, 2018 · Expires Mar 15, 2038

    granted

  16. US 9913843

    Protein kinase C inhibitors and uses thereof

    Rigel Pharmaceuticals, Inc. · Granted Mar 13, 2018 · Expires Mar 8, 2038

    granted

  17. US 9914723

    Small molecule inhibitors of Mcl-1 and uses thereof

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Mar 13, 2018 · Expires Mar 8, 2038

    granted

  18. US 9908899

    Histone deacetylase inhibitors

    BIOMARIN PHARMACEUTICAL INC. · Granted Mar 6, 2018 · Expires Mar 1, 2038

    granted

  19. US 9908878

    Inhibitors of influenza viruses replication

    Vertex Pharmaceuticals Incorporated · Granted Mar 6, 2018 · Expires Mar 1, 2038

    granted

  20. US 2018051034

    KV1.3 INHIBITORS AND THEIR MEDICAL APPLICATION

    4SC AG [DE] · Granted Feb 22, 2018 · Expires Feb 17, 2038

    granted

  21. US 9896445

    Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancer

    Ansana BioSciences, LLC · Granted Feb 20, 2018 · Expires Feb 15, 2038

    granted

  22. US 9890163

    Inhibitors of protein kinases

    Princeton Drug Discovery, Inc · Granted Feb 13, 2018 · Expires Feb 8, 2038

    granted

  23. US 9889081

    Aldehyde dehydrogenase inhibitors as novel depigmenting agents

    The Board of Regents of the University of Texas System · Granted Feb 13, 2018 · Expires Feb 8, 2038

    granted

  24. US 9890126

    Synthesis of novel inhibitors of isoprenoid biosynthesis (ISPF)

    Beryllium Discovery Corp. · Granted Feb 13, 2018 · Expires Feb 8, 2038

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.